Is Cannara Biotech Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Cannara Biotech Inc (LOVE.V) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Cannara Biotech Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cannara Biotech Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Cannara Biotech Inc?

Muslim investors may consider investing in Cannara Biotech Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Cannara Biotech Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Cannara Biotech Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Cannara Biotech Inc updated?

The Shariah compliance status of Cannara Biotech Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Cannara Biotech Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Cannara Biotech Inc?

You can check the latest Shariah compliance status of Cannara Biotech Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

LOVE.V Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 04, 2026

Report Source: 2026 1st Quarter Report

Cannara Biotech Inc. Stock Analysis LOVE.V

Canada Consumer Staples Micro Cap Report: Q1, 2026

Cannara Biotech, Inc. engages in the production of premium-grade cannabis and cannabis-derivative products. The company is headquartered in Vancouver, British Columbia and currently employs 452 full-time employees. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The company owns two mega cultivation facilities based in Quebec spanning over 1,650,000 square feet and provides up to 100 000 kilograms of annualized cultivation output. The company operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives mainly for the Canadian market. The Real estate operations is related to the Farnham and Valleyfield building. The firm's brand portfolio includes Tribal, Nugz, and Orchid CBD. Tribal delivers grade cannabis products. Orchid CBD is a wellness brand that provides CBD-rich cannabis.

Key Statistics of Cannara Biotech Inc (LOVE.V)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD1.70CAD1.75

Today's Open

CAD1.71

Volume

45.84K

P/E Ratio (TTM)

13.84

52 Week Range

CAD1.06CAD2.07

Market Cap

167.62M

Avg. Volume

57.97K

Dividend Yield

Financial Metrics & Statements of Cannara Biotech Inc (LOVE.V)

FAQ's for Cannara Biotech Inc (LOVE.V)

According to Musaffa’s Shariah screening methodology, Cannara Biotech Inc (LOVE.V) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.